Skip to main content

FDA approves pig organ transplant trials for patients with kidney failure

By The Washington Post  
   February 04, 2025

The FDA has given two biotechnology companies approval for clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure, an experimental but potentially groundbreaking innovation for thousands of Americans on the waiting list for organ transplants.

Full story


Get the latest on healthcare leadership in your inbox.